Pharming Group N.V.

Pharming is a global biotechnology company that develops and commercializes innovative medicines for people living with rare and ultra-rare immune and genetic diseases. We combine deep rare disease expertise across scientific, medical, regulatory and commercial functions to advance a focused portfolio of approved medicines and development programs addressing significant unmet medical need. Insights from patients and the wider rare disease community help shape how we identify and tackle some of the toughest rare disease challenges and deliver meaningful impact. Pharming is headquartered in Leiden, the Netherlands, with operations in the United States and Europe. Our community engagement guidelines can be found here: https://bit.ly/49nOWY3